abstract |
The present invention relates to novel di-substituted diamino-3,4-cyclobutene-3-dione-1,2 compounds having the following general formula (I): on the pharmaceutical compositions containing these compounds and on the use of these compounds and compositions for the treatment of chemokine mediated pathologies. |